↓ Skip to main content

Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials

Overview of attention for article published in BMC Endocrine Disorders, December 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials
Published in
BMC Endocrine Disorders, December 2013
DOI 10.1186/1472-6823-13-58
Pubmed ID
Authors

Asres Berhan, Alex Barker

Abstract

The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety and efficacy of SGLT2 inhibitors at different doses in randomized double blind clinical trials.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
South Africa 1 1%
Unknown 73 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 17%
Student > Bachelor 12 16%
Other 11 15%
Student > Postgraduate 7 9%
Student > Ph. D. Student 7 9%
Other 16 21%
Unknown 9 12%
Readers by discipline Count As %
Medicine and Dentistry 44 59%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Agricultural and Biological Sciences 5 7%
Nursing and Health Professions 2 3%
Engineering 2 3%
Other 3 4%
Unknown 12 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2014.
All research outputs
#1,987,698
of 4,507,509 outputs
Outputs from BMC Endocrine Disorders
#56
of 151 outputs
Outputs of similar age
#44,871
of 114,537 outputs
Outputs of similar age from BMC Endocrine Disorders
#5
of 10 outputs
Altmetric has tracked 4,507,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 53rd percentile.
So far Altmetric has tracked 151 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,537 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.